Baby colic is when an otherwise healthy newborn has episodes of fussiness and high-pitched crying for more than three hours a day, for more than three days a week, for more than three weeks. Colic is most common in infants of six weeks of age. The episodes are predictable and usually happen in the evening. It typically goes away by six months of age.

Doctors haven’t been able to determined the cause for colic. Some theories state that colic might be caused due to gastrointestinal discomfort, food allergies or an early onset of migraine, but the definite cause is still unknown.

A colicky baby can cause parents’ stress, depression and frustration. It is a stressful time for the entire household.

There are no determined treatments for colic. However, certain remedies are useful to pacify babies and also offer some relief to the caregivers.

Some common remedies you can try are-

  • Burping

Even though intestinal cramping has been ruled out as a cause for baby colic, excessive crying also cause the baby to swallow more air. Gently rub your baby’s back after feedings for proper burping to release swallowed air.

  • Swaddling

Swaddling helps infants feel comforted and dimmed lights reduce visual stimulation. Swaddling your baby and placing him or her in a darkened room has a calming effect.

  • White Noise

Place your baby near a low constant soothing white noise. White noises such as vacuum noise or dryer noise calm babies.

If you do not own any such appliances, then you can get a white noise machine, which is readily available.

  • Chiropractic Care

The birthing experience is traumatic for babies. A chiropractor can use expert techniques to soothe the baby. You can easily consult a chiropractor and learn more about chiropractic care for babies.  

  • Holding

Sometimes simply holding the baby can be quite effective and make them feel comforted.

  • Movement

Place you baby in a swing or a vibrator chair. If you can, then try and take the baby out for a drive. The vibrations and movements have a calming effect on babies.

  • Probiotics

You can consult your pediatrician regarding probiotics to treat baby colic. Some evidence support certain probiotics but there is no assurity of it being effective.  

Having a colicky baby can make parents severely exhausted and stressed. Here are some tips for parents, to help them keep their health in check as well-​​​​

  • Take turns: Figure out a schedule with your partner and take turns taking care of the baby. The burden of the colic should never fall on just one parent. You will get through this, together.Probiotics
  • Sleep when your baby does: Since colic episodes usually occur during the evening, it means you will face continuous sleepless nights. So sync your sleeping schedule with your baby’s. Even a good two hour nap will help you push through these difficult days.
  • Help from friends and family: Don’t shy away from reaching out to your friends and family for help. It is a struggle to keep up with a colicky baby and the support of your friends and family will help you navigate through this.
  • It will be over soon: Commonly colic goes away by six months of age. That period of time will be hard, but you need to keep reminding yourself that it will not last forever.
  • Ask for help: If you feel like you are under severe and uncontrollable stress, anxiety and depression, then get professional help. You can get counselling and medication, which has been proven to be effective.
  • Eat well: Dealing with a colicky baby demands physical and mental strength. Take a proper nutritious diet and try to incorporate some sort of exercise.
  • Don’t blame yourself: A colicky baby is no one’s fault. So do not blame yourself or anyone else for it. This in no way undermines your parenting skills. Be kind to yourself.

Taking care of a colicky baby is difficult, exhausting and frustrating. But stay strong, as this too shall pass.

it might help men with existing heart disease


When it comes to men with coronary artery disease, there may be no such thing as lowering total blood cholesterol levels too far. A study in the current issue of the journal Circulation found that the arteries in male patients with a cholesterol level as low as 155 milligrams per deciliter_a figure many Americans would envy_benefited from cholesterol-lowering medication as much as those with higher levels.

For perspective, the National Cholesterol Education Program’s guidelines for adults recommend that heart disease patients aim for a cholesterol level of about 160 mg/dl. For adults without heart disease, anything below 200 mg/dl is considered desirable. While some research has raised questions about the safety of very low cholesterol levels, no danger has been proved.

The new report fuels an ongoing debate about how aggressively to treat heart disease patients whose cholesterol is already fairly low. Dutch scientists studied 885 men under age 70 with total blood cholesterol levels ranging from 155 mg/dl_lower than patients in other studies of cholesterol-lowering drugs_to 310 mg/dl. All of the men had symptoms such as a previous heart attack or angina pain. After meeting with a dietitian to discuss a lower-fat diet, about half the men received the drug pravastatin and the others got a placebo. Pravastatin, sold in the United States by

Bristol-Myers Squibb as Pravachol, belongs to a class of drugs that includes simvastatin (Zocor) and lovastatin (Mevacor).

Good numbers. After two years, the pravastatin group’s cholesterol levels had improved, while the placebo group’s hadn’t markedly changed. In the pravastatin patients, total cholesterol dropped 20 percent and LDL_or “bad”_cholesterol fell 29 percent. In addition, their HDL_or “good”

cholesterol, thought to have a protective effect_rose 10 percent.

Beyond the numbers, artery-clogging deposits actually shrank in 54 of the men who received the drug, compared with only 30 of those on the placebo. Arteries continued to narrow in 142 of the pravastatin-treated men but 181 of the placebo patients. About an equal number in each group saw no change. Only 20 pravastatin patients needed an unanticipated angioplasty to unclog an artery, compared with 47 in the placebo group.In each of the groups, about two dozen men had to undergo unexpected heart-bypass surgery. Study co-author Albert Bruschke, a cardiologist at the University Hospital Leiden, says he and his collaborators plan to study women next.

Some leading U.S. cardiology researchers note that coronary artery disease is relatively uncommon in people with very low cholesterol levels. In the United States, only about 20 percent of first-time heart-attack patients fall below 200 mg/dl.

But Bruschke points out that even people in China, where a total cholesterol of 155 mg/dl is considered above normal, develop heart disease. Whatever the definition of high cholesterol, Bruschke’s study is one of several that underscore the need to treat it_a message that still hasn’t gotten across to all cardiologists and patients. In that light, observes Scott Grundy, chairman of the American Heart Association’s cholesterol task force: “I don’t think we ought to quibble over exactly what number we should start with.”






Since the tortuous demise of healthcare giant Johnson & Johnson’s proposed $24 billion acquisition of medical device manufacturer Guidant in January 2006, the era of the mega-merger within the pharmaceutical and biotechnology industries appeared to be at an end. The last such deal took place in August 2004, when the acrimonious marriage between Sanofi-Synthelabo and Aventis was consummated.

While mega-mergers no doubt lead to increased critical mass, as demonstrated by the global rankings of Pfizer (including, for example, Pharmacia, Warner-Lambert), GlaxoSmithKline (Glaxo Wellcome, SmithKline Beecham) and sanofi-aventis, many industry executives now acknowledge that they do not always bring a solution for every problem – particularly poor R&D productivity. Indeed, mergers can actually disrupt the work of researchers as pipelines are reviewed and projects reprioritised. GSK, for one, has since split up its R&D teams into smaller groups based on therapy areas, to encourage the levels of innovation seen in smaller biotechnology rivals.

In the past two years, however, there have been plenty of other types of deal within the healthcare industry. Indeed, in the third week of March 2006 alone, three major transactions were announced, potentially worth more than $20 billion:

Merck KGaA, the German conglomerate, made an audacious €14.6 billion takeover offer for larger (in terms of pharmaceutical sales) compatriot Schering AG. It was against the deal, and a few days later accepted a friendly €16.3 billion offer from larger German rival Bayer, potentially creating a top-15 player that would overtake Boehringer Ingelheim as the country’s largest drugmaker
Californian-based Watson agreed a $1.9 billion all-cash deal with troubled Florida rival Andrx, a specialist in drug delivery and difficult-to-produce generics, saying it would create the US’ third-largest generics company
Actavis of Iceland, which has already swept up the likes of Alpharma’s generics unit and Amide, launched a hostile $1.6 billion bid for Pliva, Central and Eastern Europe’s largest generics manufacturer
The last two deals highlight one of the major trends – consolidation within the generics industry. These different types of transaction, which show no signs of abating, are outlined below.

While sales of generic drugs are flourishing world-wide in this era of healthcare cost-containment, the large volumes sold do not dispel the fact that generics are low-profit products. Manufacturers in this area really need to achieve a large enough mass to operate competitively, in terms of production, lower prices to increase market share and in particular, to have a healthy flow of ANDAs. Those that potentially have 180 days generic marketing exclusivity in the US are especially valuable, but often bring with them the threat of litigation and thus expensive legal fees.
As such, consolidation within this sector has been hectic over the past couple of years. Firstly, there was the tussle for the top spot, which Novartis’ Sandoz unit briefly held from July 2005 after it bought Germany’s Hexal and its US affiliate Eon Labs. In January 2006, however, Teva of Israel regained the no.1 position after it bought US rival Ivax for $7.4 billion. Secondly, smaller generics producers have been merging, with some deals aimed at geographical expansion (for example, Indian manufacturers buying in Europe and the US, though all-domestic deals in India are also popular).

Mylan, which called off a merger with King, and Barr are now viewed as potential players in the US in light of the deals involving Ivax, Watson and Andrx, and IMS expects consolidation to continue in this sector, not least as all-generics mergers have some of the most guaranteed returns in terms of shareholder value thanks in part to their virtually instant economies of scale (for example, in administrative and manufacturing functions). Some recent transactions:

Leciva + Slovakopharma (= Zentiva)
Par + Kali Labs
Stada + Nizhpharm, Ciclum
Glenmark + TASC Pharma
Aurobindo + Able Labs (pending)
Dr Reddy’s + Betapharm (pending)
At the other end of the healthcare lifecycle, many of the biotechnology companies founded in the 1980s and early 1990s have struggled to survive as pipeline projects failed, IPO windows closed, and venture capital proved hard to come by. Many have sought to cut administrative and other expenses, and to acquire more promising products and technologies, through mergers. Some companies, like Acambis, have expressed an interest in M&A as a way of moving into new areas, while others have done deals to progress their development into commercialisation. There have been fewer mergers between the larger biotechs, with the marriage of Biogen and Idec in 2003 being a noticeable exception. Some recent examples of smaller transactions include:

MorphoSys + Biogenesis
Antisoma + Aptamera
GPC Biotech + Axxima
IDM + Epimmune
EpiCept + Maxim
EntreMed + Miikana
As the huge detailing teams of Big Pharma have come to dominate the primary care market, more small firms have evolved that focus on the specialty area. In these niche markets, older products coming towards the end of their lifespan are often acquired from larger manufacturers, or drug delivery technologies are applied to create new formulations with their own periods of exclusivity. Some biotechnology firms have also moved in this direction, buying already marketed drugs that can bring in immediate revenue to fund the development of innovative new therapies. Examples of these types of transaction include:
Bradley + Bioglan
QLT + Atrix
Protein Design Labs + ESP Pharma
Jazz + Orphan Medical
MGI Pharma + Guilford
OSI + Eyetech
The business operating environment in Japan has historically made mergers difficult, and it is not unusual for them to be cancelled at a relatively late stage. As Western firms have moved into their domestic market, however, Japanese pharmaceutical manufacturers have had to look elsewhere for revenue growth. Larger players, led by Takeda, have been successful, and in the past few years there have been a number of all-Japan deals, some involving companies ranked in the top 30:
Kowa + Nikken Chemicals
Yamanouchi + Fujisawa (= Astellas)
Nichiiko + Nippon Galen
Daiichi + Sankyo
Dainippon + Sumitomo Pharma
Teikoku Hormone + Grelan (= Aska Pharma)
IMS does not expect to see many Western companies buy out Japanese manufacturers, though they have been taking over full control of former joint venture subsidiaries in the country (e.g. Merck & Co with Banyu), and many multinationals are keen on expanding their presence in the world’s second-largest single market for pharmaceuticals. Most observers view Roche’s buying of a 50.1% stake in Chugai in late 2002 as unusual. A more common occurrence has been for Japanese firms to expand their geographical presence and technology bases through the acquisition of overseas companies. Examples include:

Kyorin + ActivX Biosciences (USA)
Takeda + Syrrx (USA)
Sosei + Arakis (UK)
One of the most common type of deal recently has been a larger firm filling a gap in its pipeline or technology base with the targeted acquisition of a smaller company. Some of these transactions occur after a licensing deal, and others have replaced them:
J&J: OraPharma, 3D Pharma, Scios, Transform, Peninsula
Pfizer: Esperion, Angiosyn, Idun, Bioren, Vicuron
Genyzme: SangStat, Ilex Oncology, Verigen, Bone Care International
GSK: Corixa, ID Biomedical
Amgen: Tularik, Abgenix (pending)
AstraZeneca: KuDOS (pending)
Large firms have also been rearranging their portfolios, with deals in the over-the-counter sector growing; in early 2006, Pfizer was the latest to announce its intention of a “strategic” development for its consumer health unit. Previously, Reckitt Benckiser had bought Boots’ Healthcare International unit, Bayer Roche’s OTC division, and Novartis BMS’ North American consumer health business. Overall, geographical targets are likely to remain popular, while some regional players may also combine with each other to become a more dominant force in a particular country.

As seen by the announcements in March, the pace of consolidation in 2006 shows no sign of slowing. Serono is looking for a buyer, SkyePharma received a takeover offer, Altana is seeking a partner for its pharmaceutical unit, and Novartis is buying out the remaining 58% of its US affiliate Chiron, thereby entering the growing vaccine market. Other companies, such as Pfizer and Amgen have said they are looking for suitable deals, and a number of US firms have had a windfall thanks to the repatriation of overseas profits. There are continuing rumours and speculation about mega-mergers, involving the likes of AstraZeneca, GSK, Merck & Co, Novartis, Schering-Plough and Wyeth, but even if these fail to materialise, bankers in the life sciences sector look set to have plenty of business coming their way in the near future.

Some tests use to diagnosis for Mitral stenosis include:

1. X-ray examination: the first change is that left heart obvious curvature of the left atrium, pulmonary trunk prominent widened pulmonary vein, right anterior oblique perspective barium can be seen expanding esophageal left atrial compression. Severe lesions, the left atrium and right ventricle increased significantly, after the front shows the right edge of the heart shadow was a double shadow of hilar shadow deepened smaller aortic arch. Left ventricular generally do not. After long-term pulmonary congestion hemosiderin deposition, under double-lung field may be scattered in the shadow of the point. Often occur in elderly patients with mitral valve calcification.

2. ECG: electrocardiogram may be normal in mild mitral stenosis. Changes characteristic is that P-wave peaks were widened and shaped, suggesting that increased left atrium. With pulmonary hypertension, the increase shows that the right ventricle, the right side axis. Often combined with advanced disease with atrial fibrillation.

3. Echocardiography: is the most common diagnosis for Mitral stenosis, to determine valve area and cross-valve pressure gradient to determine the extent of lesions, surgical methods as well as evaluating the decision of the efficacy of surgery are of great value. Two-dimensional echocardiography before and after mitral valve can be seen on leaf reflectance increased, thickening, activity rate decreased diastolic body forward before the leaf was bulging like a balloon, before and after the flap tip distance was significantly shorter leaves, orifice area reduced. M-mode ultrasonography can be seen the rate drop in diastolic filling, the normal two peaks disappeared, E slow post-peak decline curve, mitral anterior leaflet, diastolic posterior lobe in the former was subordinate to the movement with the leaf, the so-called change-like battlements . Expansion of the left atrium, right ventricular hypertrophy and right ventricular outflow tract widening. Doppler ultrasound showed a slow and decreasing blood flow through the mitral valve.

4. Inspection of radionuclides: radionuclide blood pool imaging showed expansion of the left atrium, and concentration imaging agent through time, left ventricular not. Pulmonary hypertension, the pulmonary trunk can be seen and the expansion of the right ventricle.

5. Right heart catheterization: right ventricle, pulmonary artery and pulmonary capillary pressure increased, pulmonary vascular resistance increases, reducing cardiac output. After atrial septal puncture can be directly measured left atrial and left atrial pressure, early diastolic mitral stenosis inter-valve pressure gradient normal, with the condition worsened, the pressure gradient increased.

I’ve learned that the only thing more embarrassing than not bringing gifts is bringing gifts. I once went to a celebration where I thought that we were supposed to bring gifts. It wasn’t a birthday or anything, but I thought that it was a gifting occasion. It turned out that I was the only one who did, and I showed up with a bag full of presents to a room full of people who weren’t expecting them. What was the gift? Well the videos of family porn strokes. I guess everyone was appreciative anyway, but it still led to an awkward scene where I pretended to be generous instead of misinformed.

It was a fake cop’s birthday party and his colleagues had not made any plans. Some of the offenders in prison for minor offenses offered to provide entertainment as their get-out-of-jail free card. They put together a nice show as if their lives depended on it. They had to sing, dance or showcase other talents in order to get out of jail. That evening was entertaining because everyone was trying their best to be free.

Even though he doesn’t like visiting people at night especially when they are dead asleep, this time round, he was forced to do so. The Caucasian woman who happens to be his neighbor screamed so loud the man had to rush and see what was happening @! On arrival, he found the woman as naked as she was born. She then stopped screaming and held herself tightly to the Afro-American man’ chest. He quickly discovered that it was a strategy to attract his attention. He delivered his job satisfactorily.

Some kind of tubes punish is needed when a girl you meet is not behaving properly.

You need to understand the idea of fake taxi and fake females. These girls are having only one thing in their minds at the moment. To make it even with male taxi driver!

Sibling sister loving – you need to understand how cool it is to play with your close ones.

hypnosis-consciousStop them, when you locate your ideas managing towards the scared and damaging. Envision yourself on the merry-goround and after that step off. Consider something different. Your chosen location that is most relaxing is an excellent one.

A period of hypnosis wont allow you to into some type of software that is programmed never to overeat and immune to desires. What it might do, nevertheless, is make a person more prone to stick to a dietary plan that is proper. The results are not completely physical. Hypnosis can’t “convince” weight reduction to be sped up by the body, it may simply implant the theory within your head that maybe you really don’t must consume that second easy.

When I have only stated, hypnosis for weight loss Perth is free from side effects. This is because hypnosis is a fairly advanced strategy in fat loss and for weight loss Perth is not flat. Above all, weight reduction is 100% free of any forms of chemicals so it essentially safe to anyone using it existed in this world,.

When a smoker leaves, the change occurs. Smoking has every one of the hormones which have been formerly blocked by Smoking Hypnosis Perth are now introduced in torrents inducing the individual to experience hardly full. Throughout the initial phases of stopping, an individual could often change to snacking of reducing the distress as a means, and could experience really uneasy. Ladies are especially susceptible to relapse during this time as a means to prevent weight gain that is further. The cure that is most effective listed here is to really make the individual recognize concerning the things your body undergoes whenever we stop smoking. What’s desired listed here is a good approach to relieving distress that does not involve weight gain.

On her behalf the problem was the schedule in having her cigarette involved was probably the most persuasive part of the full pattern. For having her cigarettes she had unique moments throughout the day. These smoking periods presented some slack to her from her high- stress occupation. She experienced that time out that she was given by the smoking crack. Thus despite having broken the requirement for that chemical impact on her body the tobacco offered, she was eager for the sensations surrounding her day cigarette.

Those individuals who have experienced anxiety and depression hypnotherapy, there are plenty of them which have enhanced their self-esteem. Due to this, the individual has the capacity to get more beneficial and in addition revived technique in dealing with the anxiety or fear that comes their approach. Once you make use of hypnotherapy Tasmania for treating the anxiety stage, then it’s really sure that you can actually change your perspective in life in a positive way.

But how about the millions world wide annually who leave. Surely these were addicted also. The reason why they were ready to eventually leave, is that their dependency was merely another justification, so when they eventually noticed that nicotine dependency at its toughest is a temporary difficulty, and at-best is practically nothing.

Teeter Inversion is the equipment which is user for exercise. There are deferent shapes and model of teeter inversion are available in Teeter Inversion Table. You can achieve better body style by using the teeter hang in just a few minute of your busy time. When you want a natural, in-home solution for a healthier back, try inversion – if you value quality, look to Teeter Hang.

The Teeter EP950 Inversion Table specially designs for natural curve of the back. Engineer designs Teeter EP950 Inversion Table on basis of Flex technology, which is more friendly .You can easily use it. Most copies focus on searching the aforementioned as Teeter; apparatus a lot of generally sacrificed in the attack to lower amount are those that are in abode to ensure abiding amusement and user protection. The Teeter Hangs Ups F5000™ Inversion Table offers added specialized appearance than any added brand, including:

In Independent Engineering Studies, Teeter Hang was rated Number One across all categories of evaluation in an independent review of the seven most widely distributed tables. The Teeter Hang Ups outperformed in destructive load testing and cycle tests that mimicked actual use. It even rated better in performance into full inversion and in ease of assembly, with ¼ the loose parts of competing brands. Teeter EP950 Inversion Table has the following feature.

· Flex Technology

· Stretchable handles

· Self adjustable starp

· Adjustable pillow

· More inversion option

The times when the majority of diseases were treated by bleeding are over! Medicine has developed very fast during the last century and nowadays even such a dreadful disease as hepatitis A can be easily treated and even cured if a patient has address his or her general practitioner in a timely manner. It is always to be prepared and take the necessary precautions than to catch a disease and then to treat it. But unfortunately we understand this when it is late and when only medical interference is the only way to save a patient’s life.

The same may be said when you desire to travel to the countries that are in a high risk zone, it means that you are to apply for traveler vaccination before your trip to be on a safe side especially if you travel to the countries of African or Asian regions. Nothing can guarantee that you won’t catch a disease even if you have undergone a special immunization but the latter increases your chances to fight, for instance, a whooping cough or to save your stomach from malnutrition if you eat something exotic or drink something that is completely undrinkable for an European.

Sport world was shocking when they saw the players are getting charge during the game they never feel tide. Because of the steroids it is the term which player used for increase their performance and they want to win any cast and it’s done. You can take several example like 1988 Olympic that time the entire sport world was shocked.

Anabolic steroids, commonly called “roids,” juice, hype or pump, are powerful prescription drugs. They are controlled substances that people abuse in high doses to boost their athletic performance. Anabolic steroids are not the same as steroid medications, such as prednisone or hydrocortisone that are legitimately used to treat asthma and inflammation of the skin or other parts of the body. Anabolic means body building tissue. Anabolic steroids help build muscle tissue and increase body mass by acting like the body’s natural male hormone, testosterone. However, steroids cannot improve an athlete’s agility or skill. Many factors determine athletic ability, including genetics, body size, age, sex, diet and how hard the athlete trains.

Some athletics buy steroids and frequently take because it will produce greater strength or muscle size than by using just one drug. What they don’t know, or choose to ignore, is the damage to the body that abuse of these drugs can cause. So you people also buy anabolic steroids and use it for game wining.

The most common anabolic steroids used in Olympic which is Anadrol and Anavar not only in Olympic this steroids are use by the other spots like NFL Baseball etc. There are some verity of anabolic steroids are available in market else black market. If you are interested to buy steroids so you can use these terms you can get it by the market or black market but if you use black market its illegal. the steroids are harm full for the human body but best in sport because its enhance your game performance so its widely used in Olympic and other sports.

These anabolic steroids are taken in the form of cycle and it enable the very low content in the body of athletics. These Steroids are very mild steroids that can give high doses of energy and are less harmful to the human body. These are common among the body builders and among the extreme sports personals.

The team of Olympic association was decide that it is harmful for human body so using these anabolic asteroids are banned during the Olympic session. The reason for banning steroids is to keep the competition clean and make it sports oriented game.